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ABSTRACT 
We investigate a two-strain disease model with amplification to simulate the prevalence of drug-
susceptible (s) and drug-resistant (m) disease strains. We model the emergence of drug resistance as 
a consequence of inadequate treatment, i.e. amplification. In this case, individuals infected with the 
drug-susceptible strain acquire drug-resistant infection such that the strains are coupled. We perform 
a dynamical analysis of the resulting system and find that the model contains three equilibrium points: 
a disease-free equilibrium; a mono-existent disease-endemic equilibrium with respect to the drug-
resistant strain; and a co-existent disease-endemic equilibrium where both the drug-susceptible and 
drug-resistant strains persist. We found two basic reproduction numbers: one associated with the 
drug-susceptible strain (R0s); the other with the drug-resistant strain (R0m), and showed that at least 
one of the strains can spread in a population if max[R0s, R0m] > 1 (epidemic), but are maintained in 
that population without the need for external inputs when the effective reproduction number is equal 
to 1. Furthermore, we also showed that if  R0m > max [R0s, 1], the drug-susceptible strain dies out 
but the drug-resistant strain persists in the population; however if  R0s > max [R0m, 1], then both the 
drug-susceptible and drug-resistant strains persist in the population. We conducted a local stability 
analysis of the system equilibrium points using the Routh-Hurwitz conditions and a global stability 
analysis using appropriate Lyapunov functions. Sensitivity analysis was used to identify the most 
important model parameters through the partial rank correlation coefficient (PRCC) method. We 
found that the contact rate of both strains had the largest influence on prevalence. We also 
investigated the impact of amplification and treatment/recovery rates of both strains on the 
equilibrium prevalence of infection; results suggest that poor quality treatment/recovery (drugs) 
make coexistence more likely but increase the relative abundance of resistant infections.  
Keywords: drug resistance, multi-strain, stability analysis 
 
1 Introduction 
Many pathogens have several circulating strains. The presence of more than one strain of the 
pathogen is mostly due to incorrect treatment, poor adherence, malabsorption, and treatment with 
antibodies or antiviral drugs leading to the acquisition of resistance, i.e. amplification [1-3]. The 
growing threat of several strains including a drug-resistant strain presents a significant challenge 
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throughout the world, particularly in developing countries and those with lower socio-economic status 
[4]. Once subsequent transmission of drug-resistant strains has emerged in a population, these strains 
may also contribute to the disease burden (in addition to amplification) [5]. Thus, one of the major 
challenges in preventing the spread of infectious diseases is to control the genetic variations of 
pathogens through proper treatment regimens [6, 7]. Recent studies [8-12] have shown that drug-
resistant strains can possess higher virulence to transmit disease than drug-susceptible strains, and 
those individuals infected with a drug-resistant strain have the highest mortality rate, e.g. tuberculosis 
and HIV.  
 
To examine the great threat posed by genetic variations of pathogens, we present a two-strain (drug-
susceptible, and drug-resistant) SIR epidemic model with coupled infectious compartments and use it 
to investigate the emergence and spread of mutated strains of infectious diseases. We consider the 
possibility that an individual’s position changes from drug-susceptible at initial presentation to 
resistant at follow-up. This is the mode by which drug resistance first emerges in a population and is 
designed to reproduce the phenotypic phenomenon of amplification. The model can be applied to 
investigate the co-existent or competitive exclusive phenomena among the strains.   
 
Explicitly, in this paper we perform a rigorous analytical and numerical analysis of the proposed two- 
strain model properties and solutions from both the mathematical and biological viewpoints. For each, 
we used the next generation matrix method to determine analytic expressions of the basic 
reproduction numbers of the drug-susceptible and drug-resistant strains and found that these are 
important determinants for regulating system dynamics.  With a focus on the early- and late-time 
behavior of the system, we outline the required conditions for disease fade-out, infection mono-
existence, and co-existence.  
 
To supplement and validate the analytic analysis, we use numerical techniques to solve the model 
equations and explore the epidemic trajectory for a range of possible parameter values and initial 
conditions. The local stability of three system equilibria is examined using the Routh-Hurwitz 
conditions and the global stability of the disease-free equilibrium and mono-existent disease-endemic 
equilibrium is examined using appropriate Lyapunov functions. Following this, we perform a sensitivity 
analysis to investigate the model parameters that have the greatest influence on disease prevalence. 
 
The remainder of this paper is constructed as follows: in section 2 we present the two-strain SIR model 
with differential infectivity and amplification, and verify the boundedness and positivity of solutions 
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as well as the existence of several equilibria. Local and global stability analyses of the equilibria are 
presented in section 3. In section 4 we discuss a sensitivity analysis of the model outputs. We then 
provide numerical simulations to support analytic results in section 5. Finally, in section 6, we provide 
a summary of our outcomes, discuss their importance for public health policy and propose guidelines 
for future effort. 
2. Model description and analysis 
 
Model equations: 
We developed a transmission dynamic two-strain SIR model for drug-susceptible and drug-resistant 
cases, and divided the total population into four subclasses: S −susceptible individuals; Is – individuals 
infected with the drug-susceptible strain; Im – individuals infected with the drug-resistant strain; and 
R – recovered individuals, who are assumed to have immunity against both strains. Thus the total 
population number N(t) at time t is  
N(t) = S(t) + Is(t) + Im(t) + R(t).                                                                                                             (1)  
We also introduced the following parameters: Λ – constant recruitment rate into the susceptible class 
through birth or immigration; μ – natural death rate; βs (βm) – effective contact rate of individuals 
with drug-susceptible (drug-resistant) infection; ωs (ωm) – treatment/recovery rate for drug-
susceptible (drug-resistant) infected individuals; ϕs (ϕm) – disease related death rate for drug-
susceptible (drug-resistant) infected individuals; ρ – proportion of individuals who amplify from the 
drug-susceptible strain to the drug-resistant strain during treatment/recovery. We assumed the 
proportion of individuals who amplify – due to incomplete treatment or lack of compliance in the use 
of first-line drugs – move directly from the drug-susceptible compartment Is into the drug-resistant 
compartment Im. The model structure is illustrated in Fig. 1. 
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Fig. 1. Flow chart of the two-strain SIR model showing the four infection states, and the transition rates in and out of each state (not shown: 
the constant recruitment rate Λ into the susceptible compartment S). Subscripts s and m denote drug-susceptible and drug-resistant 
quantities respectively. 
From the aforementioned, the populations in each disease state are determined by the following 
system of nonlinear ordinary differential equations: 
Ṡ = Λ − μS− βsIsS − βmImS,                                                                                                                        (2) 
İs = βsIsS− (ωs +ϕs +μ)Is,                                                                                                                        (3)              
İm = ρωsIs +βmImS− (ωm +ϕm+μ)Im,                                                                                                (4)                                                                                                    
Ṙ = (1 − ρ)ωsIs+ ωmIm−μR.                                                                                                                     (5) 
Given non-negative initial conditions for the system above, it is straightforward to show that each of 
the state variables remain non-negative for all t > 0. Moreover, summing equations (2) – (5) we find 
that the size of the total population, N(t) satisfies 
Ṅ(t) ≤ Λ− μN. 
Integrating this equation we find 
N(t) ≤
Λ
μ
+N(0)e−μt.         
This shows that the total population size N(t) is bounded in this case and that it naturally follows 
that each of the compartment states S, I, etc. are also bounded. 
Note that equations (2)-(4) are independent of the size of the recovered population R(t); therefore, 
if we only wish to track disease incidence and prevalence, we can focus our attention on the following 
reduced system (6)-(8): 
Ṡ = Λ − μS− βsIsS − βmImS,                                                                                                                        (6) 
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İs = (βsS− χs)Is,                                                                                                                                              (7)            
İm = ρωsIs +βmImS− χmIm,                                                                                                                        (8)      
 where, χs = ωs + ϕs+μ and χm = ωm +ϕm+μ represent the total removal rates from the 
respective infectious compartments. 
Given the positivity and boundedness of the system solutions, we find that the feasible region for 
equations (6) – (8) is given by 
D = { (S,   Is,   Im) ∈ ℝ+
3 ∶ S + Is + Im ≤
Λ
μ
}                                                                                                  (c) 
where D is positively invariant. Therefore, in this study we consider the system of equations (6) – (8) 
in the set D. 
   
2.1 Basic reproduction number 
Here we estimate the basic reproduction number of the model (6) -(8). In an epidemic model, the basic 
reproduction number is an important quantity that reflects the expected number of secondary cases 
created by a single infectious case introduced into a totally susceptible population. If the basic 
reproduction number is greater than one, the number of infected individuals grows and the infection 
will show persistent behavior. Conversely, if the basic reproduction number is less than one, the 
number of infective individuals typically tends to zero [13-15]. Here we use the next generation matrix 
technique to estimate the basic reproduction number(s) of our system. 
 
The reduced model (6)-(8) has two infected states, Is and Im, and one uninfected state, S. At the 
infection-free steady state Is
0 = Im
0  = 0, hence, from (6), S0 =
Λ
μ
.  When we linearize the system about 
the infection-free equilibrium equations (3) − (4) are closed, and we have 
İs = (βsS
0 − χs)Is,                                                                                                                                              (9)            
İm = ρωsIs +βmImS
0− χmIm.                                                                                                                     (10)       
Here, the ODEs (9) and (10) are referred to as the (linearized) infection subsystem, as they only 
describe the production of newly infected individuals and changes in the states of already infected 
individuals. 
By setting 𝐱T = (Is, Im)
T, where T denotes transpose, the infection subsystem can be written in the 
following form: 
?̇? = (𝑇 + Σ)𝐱.                                                                                                                                                    (11) 
The matrix 𝑇 corresponds to transmission (arrival of susceptible individuals into the infected 
compartments Is and Im) and the matrix Σ to transitions (i.e. recovery, amplification and death).  
For the subsystem (9) − (10) we obtain 
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𝑇 = (
βsS
0 0
0 βmS
0
) and Σ = (
−χs 0
ρωs −χm
). 
The next generation matrix, K, is given by [13] 
K = −𝑇Σ−1 = (
S0βs
χs
0
S0βmωsρ
χsχm
S0βm
χm
). 
The dominant eigenvalues of K are the basic reproduction numbers for the drug-susceptible and drug-
resistant strains; they represent the average number of new infections from each strain produced by 
one infected individual. Hence, the basic reproduction numbers for the drug-susceptible and drug-
resistant strains are:  
R0s =
S0βs
χs
=
Λ βs
μχs
,                                                                                                                                                (a) 
and 
R0m =
S0βm
χm
=
Λ β𝑚
μχm
.                                                                                                                                            (b) 
Interestingly we find that the basic reproduction numbers R0s and R0m are purely a function of the 
epidemiological parameters of the drug-susceptible and drug-resistant strains respectively, i.e. both 
are independent of the amplification rate ρ [16]. 
 
Given these expressions (a)-(b) for the basic reproduction numbers of each strain, we can now 
investigate the relationship between the fitness cost, c, exacted on the transmissibility of drug- 
resistant strain m, and its resistance to treatment, ϵ, on the relative fitness of strains m and s. 
 
If we assume that both R0s and R0m are greater than 1, then the condition for resistant infections to 
outcompete sensitive infections is given by, 
R0m > R0s. 
Substituting the formulae (a)-(b) for the basic reproduction numbers gives: 
Λβm
ωm +ϕm+μ
>
Λβs
ωs +ϕs+ μ
. 
If we consider that resistance exacts a fitness cost, c, on the transmissibility of the drug-resistant 
strain, it follows that 
βm = (1 − c)βs. 
Further, if we assume that strain m has a level of resistance, ϵ, to treatment we have  
ωm = (1− ϵ)ωs. 
Lastly, assuming that μ ≈ 0 (since it is very slow compared to the other rates) and that ϕm ≈ ϕs 
yields the condition 
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Λ(1− c)βs
(1− ϵ)ωs +ϕs
>
Λβs
ωs +ϕs
 
which we can rearrange to obtain 
ϵ >
c(ωs+ ϕs)
ωs
. 
The above relation shows that the resistant strain can outcompete the susceptible strain if the 
resistance level ϵ is high (which may be the case for drug-resistant individuals) and/or the death rate 
due to infection is high, which may occur as a result of poor medical care. Alternatively, the resistant 
strain will be fitter than the susceptible one if the fitness cost c is sufficiently low. 
 
2.2 System properties  
 
Table 1: Description and estimation of model parameters 
Parameters 
                                 
Description Estimated  value       References 
 
Λ 
 
μ 
 
Recruitment rate in to the population 
 
Death rate 
 1 
1
70
 per year                               [17] 
 
βs Contact/transmission rate for drug susceptible population variable                                     - - 
 
βm Contact/transmission rate for drug resistant population variable                                      - - 
 
ωs Recovery rate for drug susceptible population 0.2906 per year                        [18]                     
   
ωm Recovery rate for drug resistant population 0.1453  per year                Assume 
 
ρ Proportion of amplification 0.035                                         [19] 
 
φs Disease related death rate for drug susceptible population 0.37 over 3 year                       [19] 
 
φm Disease related death rate for drug-resistant population 0.37 over 3 year                       [19] 
 
2.2.2 Existence of equilibria 
Clearly, equations (6) – (8) always have a disease-free equilibrium 
 E0 = (S0, Is
0,   Im
0 ) = (
Λ
μ
,   0,   0).  
From equation (6)-(8) we can also derive the mono-existent endemic equilibrium point E1 =
(S1, 0, Im
1 ) at which the drug-resistant strain persists and the drug-susceptible strain dies out:  
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S1 =
S0
R0m
=
Λ
μR0m
,  
Is
1 = 0, 
Im
1 =
μ(R0m−1)
βm
.                                                                                                                                                  (13) 
From (13) we see that E1 = (S1, 0, Im
1 ) ∈ D if, and only if R0m ≥ 1. 
Next, the co-existent endemic equilibrium of the system is examined. If E2 = (S2, Is
2, Im
2 ) is any co-
existent endemic equilibrium, from equations (6)—(8), we obtain 
S2 =
Λ
μR0s
=
S0
R0s
,        
Is
2 =
μ (R0s−1)
βs
 Ψ,  where Ψ = (1 +
ρωsR0sβm
βsχm (R0s−R0m)
)
−1
= (1+
ρωs R0m
χs (R0s−R0m)
)
−1
 > 0 if R0s > R0m,  
Im
2 =
ρR0sωsμ (R0s−1)
βs χm (R0s−R0m)+ρR0sωsβm
,                                                                                                                      (14) 
       =
ρωsR0s
χm(R0s−R0m)
 
μ (R0s−1)
βs
 Ψ.                                                                                                          
Equation (14) shows that if R0s > max[R0m,   1] then the co-existent endemic equilibrium E
2 =
(S2, Is
2, Im
2 ) ∈ D. 
 
3. Stability analysis 
 
Since equations (2) – (4) are independent of equation (5), we can focus our attention on equations 
(6) - (8) to study the persistence of the infection. To investigate stability of the equilibria of 
equations (6)—(8), the following results are established: 
 
3.1 Infection-free equilibrium 
Lemma 1: If R0 = max[R0s, R0m] < 1, the disease free equilibrium E
0 of (6)—(8) is locally and 
globally asymptotically stable; if, however, R0 = max[R0s, R0m] > 1, E
0 is unstable. 
Proof: We consider the Jacobian of the system (6)—(8) which is given by  
J = (
−βsIs− βmIm−μ −βsS −βmS
βsIs βsS− χs 0
βmIm ρωs βmS− χm
). 
At the infection-free equilibrium point, E0, this reduces to  
J0 = (
−μ −βsS
0 −βmS
0
0 χs(R0s −1) 0
0 ρωs χm(R0m− 1)
). 
The structure of J0 allows us to immediately read off the 3 eigenvalues, λi , as 
λ1 = −μ , λ2 = χs(R0s − 1),and λ3 = χm(R0m− 1).                                                                               (15) 
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It is easy to verify that all the roots of the characteristic equation (15) have negative real parts for                          
R0s < 1 and  R0m < 1. Hence, the disease free equilibrium E
0 of (15) is locally asymptotically stable 
for R0s < 1 and  R0m < 1. If R0s > 1 or  R0m > 1, at least one of the roots of the characteristic 
equation (15) has a positive real part. Hence, in this case, E0 is unstable. 
Now the global stability of the disease free equilibrium E0 for R0s < 1 and R0m < 1 can be 
investigated. In fact, from equation (7), we have 
İs = (βsS− χs)Is.     
Integrating gives 
Is(t) = Is(0)e
∫ βs S(τ)dτ
t
0 −χs t                                                                                                                         (16) 
for all t ≥ 0.  
Substituting in the condition S(t) ≤
Λ
𝜇
= S0, which follows immediately from the definition of D 
(equation (c)), we obtain 
Is(t) ≤ Is(0)e
∫ βs (
Λ
μ
+S(0)e−μτ)dτ−χs t
t
0 , 
         ≤ Is(0)e
(βsS
0−χs)t  
         ≤ Is(0)e
χs(R0s−1)t 
It follows then that if R0s < 1 we have Is(t) → 0 as t → ∞. 
Hence the hyperplane Is = 0 attracts all solutions of (6) – (8) originating in D whenever R0s < 1.  
Since Is(t)→ 0 as t → ∞ for R0s < 1, it follows that ρ ωsIs(t)→ 0, such that equation (8) reduces to  
İm = βmImS− χmIm.      
Following the same strategy for Im as we used above for Is yields 
Im(t) ≤ Im(0)e
χm(R0m−1)t. 
It follows then that if R0m < 1 that Im(t)→ 0 as t → ∞ and the hyperplane Im = 0 attracts all 
solutions of (6) – (8) originating in D. Moreover, it is straightforward to show that if Is → 0, and Im →
0, then S → S0.  Therefore E0 is globally asymptotically stable when R0 = max[R0s, R0m] < 1. 
 
3.2 Mono-existent endemic equilibrium 
Lemma 2: If the boundary equilibrium E1 = (S1, 0, Im
1 ) of the equations (6)—(8) exists and  
R0m > max [1, R0s], E
1 is locally and globally asymptotically stable. 
Proof: We consider the Jacobian of the system (6)—(8) at the mono-existent endemic equilibrium 
point E1which is given by  
10 
 
J1 =
(
 
 
−βmIm
1 −μ −βsS
1 −βmS
1
0 −
χs(R0m−R0s)
R0m
0
βmIm
1 ρωs 0 )
 
 
. 
The structure of J1 allows us to immediately read off the first eigenvalue, λ1 = −χs
(R0m−R0s)
R0m
, and 
the remaining eigenvalues we can calculate from the following expression 
 (λ2 + a1λ+ a2) = 0                                                                                                                                   (17) 
where, 
a1 = βmIm
1 +μ = μR0m, 
a2 = βm
2 Im
1 S1= μχm(R0m−1).  
For local stability we must ensure that the Routh-Hurwitz criteria [20] are satisfied: 
a1 > 0,   which is true;  
a2 > 0,  which holds whenever R0m > 1. 
Finally, the remaining root of the Jacobian J1 is λ1 = −χs
(R0m−R0s)
R0m
< 0 for  R0m > R0s. Thus, by the 
Routh-Hurwitz criteria, the boundary equilibrium E1 is locally asymptotically stable whenever R0m >
max [1,R0s]. Conversely, for E
1∈ D, it is unstable when R0m < R0s. 
Now we prove E1  is globally asymptotically stable if R0m > max [1, R0s]. Considering equation (7) 
and (8), we get 
İs = (βsS− χs)Is,                                                                                                                                             (18)                                                                                                  
İm = ρωsIs +βmImS− χmIm.                                                                                                                       (19)                                                                                             
Following [21] first, we divide equation (18) and (19) through by Is and Im respectively to obtain 
dlog Is
dt
= βsS − χs                                                                                                                                              (20) 
dlog Im
dt
= βmS− χm +ρωs
Is
Im
                                                                                                                         (21) 
Rearranging equations (20) and (21) to solve for S we get 
S =
1
βs
dlog Is
dt
+
χs
βs
=
1
βm
d logIm
dt
+
χm
βm
−
ρωs
βm
Is
Im
.                                                                                              (22) 
From (22), we obtain the following inequality 
1
βs
d logIs
dt
+
χs
βs
≤
1
βm
dlog Im
dt
+
χm
βm
 
Integrating both sides gives 
(
Is(t)
Is(0)
)
1
βs
e
χs
βs
t
≤ (
Im(t)
Im(0)
)
1
βm
e
χm
βm
t
 
which we can rearrange to obtain 
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(
Is(t)
Is(0)
)
1
βs
≤ (
Im(t)
Im(0)
)
1
βm
e
(
χm
βm
−
χs
βs
)t
. 
Using equations (a) and (b) for the basic reproduction numbers, we get 
(
Is(t)
Is(0)
)
1
βs
≤ (
Im(t)
Im(0)
)
1
βm
e
S0(
1
R0m
−
1
R0s
)t
. 
Since both Is(t) and Im(t) are bounded, taking the limit as t → ∞ we find 
lim
t→∞
(
Is(t)
Is(0)
)
1
βs≤ lim
t→∞
(
Im(t)
Im(0)
)
1
βme
S0(
1
R0m
−
1
R0s
)t
→ 0 for R0m > R0s. 
Hence the hyperplane Is = 0 attracts all solutions of (6) – (8) when R0m > R0s.  
We now show the endemic equilibrium E1 is globally asymptotically stable on the hyperplane Is = 0 
by constructing the following Lyapunov function [22]: 
Let 
V1 = S − S
1 lnS + Im− Im
1 ln Im+ C 
where 
C = −(S1 − S1 lnS1 + Im
1 − Im
1 ln Im
1 ). 
Taking the derivative of V1(t) along system trajectories yields 
V̇1 = (1−
S1
S
)Ṡ + (1−
Im
1
Im
) İm, 
= (1−
S1
S
)(Λ − μS− βmImS) + (1−
Im
1
Im
)(βmImS− χmIm) 
= Λ− μS − βmImS− Λ
S1
S
+ μS1+ βmImS
1+βmImS− χmIm−βmIm
1 S+ χmIm
1 . 
First, we substitute in the identity 
Λ = μS1+ βmIm
1 S1 
to obtain 
V̇1 = μS
1 +βmIm
1 S1−μS − μS1
S1
S
− βmIm
1 S1
S1
S
+ μS1+βmImS
1− χmIm−βmIm
1 S+ χmIm
1  
= μS1 (2−
S
S1
−
S1
S
)+ βmIm
1 S1−βmIm
1 S1
S1
S
+ βmImS
1− χmIm−βmIm
1 S+ χmIm
1 . 
We can simplify this expression further by substituting in the identity 
βmS
1 = χm 
to get 
V̇1 = μS
1 (2−
S
S1
−
S1
S
)+ χmIm
1 − χmIm
1
S1
S
+ χmIm− χmIm− χmIm
1
S
S1
+ χmIm
1  
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= μS1 (2−
S
S1
−
S1
S
)+ χmIm
1 (2−
S
S1
−
S1
S
) 
= (μS1 + χmIm
1 )(2−
S
S1
−
S1
S
). 
Since the arithmetic mean is greater than or equal to the geometric mean, we obtain 
V̇1 ≤ 0. 
Therefore, the mono-existent endemic equilibrium E1 is globally asymptotically stable if R0m > 1. 
 
3.3 Co-existent endemic equilibrium 
We now show the stability analysis of the co-existent endemic equilibrium E2= (S2, Is
2,Im
2 ). 
Lemma 3: If the endemic equilibrium E2 = (S2, Is
2,Im
2 ) of the equations (6)—(8) exists, E2 is locally 
asymptotically stable. 
 
Proof: We consider the Jacobian of the system (6)—(8) at the co-existent endemic equilibrium point 
E2 which is given by  
J2 = (
−βsIs
2 −βmIm
2 −μ −βsS
2 −βmS
2
βsIs
2 βsS
2 − χs 0
βmIm
2 ρωs βmS
2 − χm
).  
Now 
−βsIs
2−βmIm
2 −μ = −μ R0s,  
−βsS
2 = −
R0s χs
S0
  
S0
R0s
= −χs,  
−βmS
2 = −
R0m χm
S0
 
S0
R0s
= −χm
R0m
R0s
,  
βsIs
2 = βs   
μ (R0s−1)
βs
 Ψ = μ(R0s −1)Ψ,  
βmIm
2 = 
ρωs
χs
  
R0m
(R0s−R0m)
 μ (R0s −1)Ψ,  
βsS
2 − χs = χs (
βsS
0
R0sχs
−1) = χs (
R0s
R0s
−1) = χs(1− 1) = 0, 
βmS
2− χm = χm (
βmS
0
χmR0s
− 1) =
χm
R0s
 (R0m−R0s). 
Given the identities above, the matrix J2 will be in the following form,  
J2 =
(
 
 
−μR0s −χs −χm  
R0m
R0s
μ (R0s −1)Ψ 0 0
ρωs
χs
 
R0m
(R0s −R0m)
 μ (R0s − 1)Ψ ρ ωs χm
(R0m−R0s)
R0s )
 
 
. 
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To determine the stability of this matrix we use the Routh-Hurwitz criteria. Specifically, all of the 
roots of the characteristic polynomial associated with a three by three matrix J2 are negative if A1 >
0, A2 > 0,A3 > 0, and A1A2 > A3, where A1 = −trace(J2), A2 represents the sum of the two by 
two principal minors of J2 and A3 = −det (J2).  
 
Condition 1: For the matrix J2, we have 
A1 = −trace (J2) > 0, 
⇒  μ R0s +
χm (R0s−R0m)
R0s
> 0, which is true if R0s > R0m. 
 
Condition 2: 
A2 = |
0 0
ρ ωs
χm (R0m− R0s)
R0s
| + ||
−μR0s −χm  
R0m
R0s
ρωs
χs
 
R0m
(R0s −R0m)
 μ(R0s −1)Ψ χm  
(R0m−R0s)
R0s
|| 
+|
−μR0s −χs
μ(R0s −1)Ψ 0
| > 0, 
⇒ μχm (R0s −R0m) +
ρωs
χs
 
χm R0m
2
R0s
 
μ (R0s −1)
(R0s −R0m)
Ψ + μχs(R0s −1)Ψ > 0,  
⇒ μχm (R0s −R0m) + μ(R0s −1)Ψ[
ρ ωs
χs
 
χm R0m
2
R0s (R0s −R0m)
+ χs] > 0.  
Recalling the definition of Ψ (equation (14)), which is positive for R0s > R0m, we see that this 
condition is satisfied whenever R0s > 1 and R0s > R0m. 
 
Condition 3: 
A3 = det (J2) < 0,  
⇒ −μ (R0s −1)Ψ |
−χs χm
R0m
R0s
ρ ωs χm
(R0m−R0s)
R0s
| < 0,  
⇒ −μ (R0s −1)Ψ [
χsχm (R0s−R0m)
R0s
+
ρ ωsχmR0m
R0s
] < 0,  
⇒ μ (R0s −1)Ψ 
χsχm (R0s−R0m)
R0s
 [1 +
ρ ωsR0m
χs (R0s−R0m)
] > 0,  
⇒ μ (R0s −1)  
χsχm (R0s−R0m)
R0s
 
Ψ
Ψ
> 0,  
⇒
μ χsχm
R0s
  (R0s −1)(R0s −R0m) > 0 , which is true if  R0s > 1 and R0s > R0m. In the fifth line we 
have substituted in the definition of Ψ given in equation (14). Finally if we multiply the expressions 
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for A1  and A2 it is straightforward to show that the condition A1A2 > A3 is satisfied. Thus, by the 
Routh-Hurwitz criterion, the co-existent endemic equilibrium E2 is locally asymptotically stable when 
R0s > 1 and R0s > R0m.  
4. Sensitivity analysis 
Recognizing the relative importance of the various risk factors responsible for transmission of 
infectious diseases is essential. The progression of the drug-resistant strain and its incidence and 
prevalence must be understood in order to determine how best to decrease disease burden. As 
demonstrated in the previous sections, the scale and severity of disease transmission is directly 
associated with the basic reproduction numbers R0s and R0m. Here, we estimate the sensitivity 
indices of the reproduction numbers R0s and R0m to the model parameters given in Table 1. The 
indices express how vital each parameter is to R0s and R0m , and , in turn, disease transmission thus 
allowing us to identify which parameters should be targeted by intervention policies.  
 
For this purpose, we calculated the partial rank correlation coefficient (PRCC) which is a global 
sensitivity analysis technique using Latin Hypercube Sampling (LHS). Specifically, a uniform distribution 
is assigned to each parameter and a total of 100,000,000 simulations are implemented. Here the 
model outputs we consider are both basic reproduction numbers, namely R0s and R0m as well as the 
sum of infectious individuals Is and Im and their total sum (Is + Im) at equilibrium. Note that the PRCC 
values lie between -1 and +1. Positive (negative) values imply a positive (negative) correlation to the 
model parameter and outcomes. The bigger (smaller) the absolute value of the PRCC, the greater 
(lesser) the correlation of the parameter to the model outcome.  
 
Fig. 2 and Fig. 3 depict the correlation between R0s, R0m, and the corresponding model parameters. 
Parameters βs and βm have positive PRCC values, implying that a positive change of these parameters 
will increase the basic reproduction numbers R0s and R0m respectively. In contrast, parameters ωs , 
and ϕs as well as ωm , and ϕm have negative PRCC values, which implies that raising these parameters 
will consequently decrease R0s and R0m, respectively.  
15 
 
 
Fig. 2. PRCC values depicting the sensitivities of the model output 𝑅0𝑠 
with respect to the estimated parameters 𝛽𝑠, ωs , and 𝜙𝑠. 
 
Fig. 3. PRCC values depicting the sensitivities of the model output 𝑅0𝑚 
with respect to the estimated parameters 𝛽𝑚 , ωm , and 𝜙𝑚. 
Fig. 4, Fig. 5, and Fig. 6 display the correlation between Is, Im and (Is + Im) and the corresponding 
parameters βs, ωs,ϕs, βm,ωm,ϕm and ρ when R0s > max [R0m,1]. From Fig. 4, Fig. 5, and Fig. 6, it is 
easy to perceive that Is and (Is + Im) has a strong positive correlation with βs and Im has a weaker 
positive correlation with βs, implying that a positive change of βs will increase Is, (Is+ Im) and Im. 
Parameters ωs and ϕs have a negative correlation with Is, Im and (Is + Im). In addition βm has a 
negative correlation with Is and (Is + Im) but a strong positive correlation with Im. Parameters ωm 
and ϕm have a positive correlation with Is and (Is + Im) but strong negative correlation with Im.  
 
Further, parameter ρ has a negative correlation with Is and (Is + Im) but a strong positive correlation 
with Im. Fig. 7 represents the correlation between equilibrium value of Im and the corresponding 
model parameters βs, ωs,ϕs, βm,ωm,ϕm and ρ when R0m > R0s and R0m > 1. Parameters βs, βm 
and ρ (small value not showing) have positive PRCC values, implying that a positive change in these 
parameters will increase Im. In contrast, ωs, ϕs,ωm and ϕm have negative PRCC values and, thus, 
increasing theses parameters will consequently decrease Im.  
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Fig. 4. PRCC values depicting the sensitivities of the model output Is 
with respect to the estimated parameters 𝛽𝑠, ωs ,  𝜙𝑠, 𝛽𝑚,  𝜔𝑚, 𝜙𝑚 
and ρ, when R0s > max [R0m, 1].  
Fig. 5. PRCC values depicting the sensitivities of the model output Im 
with respect to the estimated parameters 𝛽𝑠, ωs ,  𝜙𝑠, 𝛽𝑚,  𝜔𝑚, 𝜙𝑚 
and ρ, when R0s > max [R0m, 1].  
 
Fig. 6.  PRCC values depicting the sensitivities of the model output Is +
Im with respect to the estimated parameters  𝛽𝑠, ωs, 𝜙𝑠, 𝛽𝑚,  𝜔𝑚, 
𝜙𝑚 and ρ, R0s > max [R0m , 1]. 
 
Fig. 7.  PRCC values depicting the sensitivities of the model output Im 
with respect to the estimated parameters 𝛽𝑠, ωs ,  𝜙𝑠, 𝛽𝑚,  𝜔𝑚, 
𝜙𝑚 and ρ, when R0m > R0s and R0m > 1. 
 
From the explicit expressions for R0s and R0m given in the equation (a)-(b), analytical expressions 
for the sensitivity indices can be derived following the method in [23]. For example, for a model 
parameter δ we would have 
Υβs
R0s = 
∂R0s
∂δ
x 
δ
R0s
. 
This sensitivity index is a local measure of model behaviour in terms of the model inputs. Now using 
the parameter values in Table 1, we have the following results (Table 2).  
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Table 2: Sensitivity indices to parameters for the model (2)-(5) 
Parameter                   Sensitivity index (𝐑𝟎𝐬)                             Parameter                         Sensitivity index (𝐑𝟎𝐦) 
βs                                   + 1.000                                                          βm                                        +1.000 
 
ωs                                   - 0.431                                                         ωm                                        - 0.274  
 
ϕs                                   - 0.548                                                         ϕm                                        - 0.699 
 
 
In the sensitivity indices of R0s and R0m, the most sensitive parameters are the effective contact rate 
of drug-susceptible case, βs and drug-resistant case, βm, respectively.  Other significant parameters 
are recovery rates (ωs and ωm) and disease related death rates ( ϕs and ϕs). Since Υβs
R0s = 1, 
and  Υβm
R0m = 1, increasing (or decreasing) the effective contact rates, βs and βm of drug-susceptible 
and drug-resistant cases by 100%, increases (or decreases) the reproduction numbers R0s and R0m 
by 100%. Similarly, increasing (or decreasing) the recovery rates ωs and ωm by 100% decreases (or 
increases) R0s and R0m, by 43.1% and 27.4% respectively. In the same manner, decreasing (or 
increasing) the disease related death rates ϕs and ϕm by 100% increases (or decreases) the R0s 
and R0m, by 54.8% and 69.9% respectively.   
 
5. Numerical simulations 
In this section, we carry out detailed numerical simulations (using the Matlab programming language) 
to support the analytic results and to assess the impact of amplification and drug-susceptible 
treatment/recovery rate on equilibrium levels of total prevalence and drug-resistant prevalence. 
Three equilibrium points were found: the disease-free equilibrium E0; a mono-existent endemic 
equilibrium E1; and co-existent endemic equilibrium E2. Routh-Hurwitz conditions and the Lyapunov 
function were used to investigate the local and global stability of these points. We used different initial 
conditions for both strains of all populations and found that if both basic reproduction numbers are 
less than one (i.e. max[R0s, R0m] < 1) then the disease free equilibrium is locally and globally 
asymptotically stable. If R0m > max[R0s, 1], and the drug-susceptible strain dies out but the drug-
resistant strain persists in the population. Furthermore, if R0s > max[R0m, 1], then both the drug-
susceptible and drug-resistant strains persist in the population. Fig. 8 represents co-existent endemic 
equilibrium and we used different initial conditions for this system trajectories in the Is vs Im plane. 
In this system both strains (Is and Im) persisting; this is because the basic reproduction number of the 
drug-susceptible strain R0s was greater than one and there was an amplification pathway from the 
drug-susceptible strain to the drug-resistant strain (i.e. R0s > max [R0m, 1]). 
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Fig. 9 depicts the effect of amplification (ρ) on equilibrium levels of drug-susceptible prevalence and 
drug-resistant prevalence and shows that in the first region (ρ ≲ 0.6) the drug-susceptible prevalence 
is initially dominant but with the drug-resistant prevalence rising with increasing ρ. Eventually, for ρ ≳
0.6, the drug-resistant strain becomes dominant courtesy of the amplification pathway. Fig. 10, and 
Fig. 11 are graphical representations showing the effect of drug-susceptible strain treatment/recovery 
rate on the equilibrium level of total prevalence, and drug-resistant prevalence when both infection 
rates (βs, βm) are fixed. If we increase the proportion of amplification, both the total prevalence and 
drug-resistant prevalence also increase. However, Fig. 11 shows that for high amplification, the drug-
resistant prevalence increased when the treatment/recovery rate of the drug-susceptible strain 
moved from zero to around 0.25 to 0.30, then declined to a common point. For lower amplification 
values, the drug-resistant proportion only increased up to the common point. This point is the drug-
resistant-only equilibrium and occurs when the effective reproduction number of drug-susceptible 
strain becomes lower than the basic reproduction ratio of drug-resistant strain. Numerical simulations 
show that for sufficiently high amplification, the prevalence of the drug- resistant strain will exceed 
that of its inherent equilibrium value (that is, the resistant-only equilibrium) when the drug-
susceptible strain exists and is being treated. 
 
 
Fig. 8. Co-existent endemic equilibrium: R0s > max [R0m, 1]. In 
this case both drug-susceptible prevalence and drug-resistant 
prevalence persist in the population. 
 
 
Fig. 9. Effect of amplification (ρ) on the drug-susceptible (Is) 
prevalence and drug-resistant prevalence (Im). All remaining 
parameter values assume their baseline values given in Table 1. 
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Fig. 10. Effect of drug-susceptible treatment/recovery rate (𝜔𝑠) 
on equilibrium level of total prevalence when both infectious 
rates (βs, βm) are fixed. All remaining parameter values assume 
their baseline values given in Table 1. 
 
Fig. 11. Effect of drug-susceptible treatment/recovery rate (𝜔𝑠) on 
equilibrium level of drug-resistant strain when both infectious 
rates (βs, βm) are fixed. All remaining parameter values assume 
their baseline values given in Table 1.  
 
 
6. Discussion and conclusion  
In this study, we formulated a two-strain SIR non-constant population model with amplification and 
investigated its dynamic behavior. We considered amplification as the process by which an individual 
infected with a drug-susceptible strain acquires infection with a drug-resistant strain. Using the next 
generation matrix, we obtained the basic reproduction number of each strain, namely R0s for drug-
susceptible cases and R0m for drug-resistant cases.   We found that the basic reproduction numbers 
determine the equilibrium states of the system and their stability. Specifically if R0m  is greater than 
R0s  and unity, only the drug resistant strain will remain, whereas if R0s is larger than R0m and unity, 
a coexistence is likely. We also found that both basic reproduction numbers are independent of 
amplification rates, which indicates that the reproductive capacity of each strain is autonomous of the  
amplification rates between them.   
 
We then determined the necessary and sufficient conditions for disease extinction and disease 
endemicity according to the values of the basic reproduction numbers. As expected, the infected 
population of both strains declines rapidly and is extinguished if both basic reproduction numbers are 
less than one (max[R0s, R0m] < 1). Conversely, if R0m > max[R0s, 1], then the drug-susceptible 
strain dies out but the drug-resistant strain persists in the population. Furthermore, if R0s >
max[R0m,1], then both the drug-susceptible and drug-resistant strains persist in the population.  
We also found that the drug-susceptible strain is not necessarily the most prevalent at equilibrium 
even if it has the highest basic reproduction number. This is a consequence of the fact that the drug-
susceptible strain persists purely on direct transmission whereas the drug-resistant strain prevalence 
is driven by a combination of direct transmission and amplification. These results explain in part the 
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rise in drug-resistant strain prevalence when the drug- susceptible strain is treated. These findings can 
hopefully advise public health policy makers to formulate policy for drug-resistant prevalence since 
we have shown that the drug-resistant strain can surpass the drug-susceptible strain (i.e. become 
more prevalent) even if drug-resistant strain has a smaller basic reproduction number.  
 
Lastly we explored the effect of the drug-susceptible treatment rate on the equilibrium level of total 
prevalence and drug-resistant prevalence. We found that if we increase the drug-susceptible 
treatment rate, the total prevalence will decline. However, the response of the drug-resistant strain 
prevalence is non-monotonic, increasing for a certain period and then declining at a particular 
threshold point. This finding has important implications for choosing the proper intervention or 
treatment strategies. From a microbiological viewpoint, resistance first occurs by a genetic mutation 
in a micro-organism that leads to resistance to a treatment, modelled by reducing the treatment rate. 
Therefore, one could question whether it is prudent to risk the emergence of drug resistant strains by 
increasing the treatment rate of the drug-susceptible strain. However, at least initially, such 
resistance-conferring mutations typically exact a “fitness cost” whereby drug-resistant organisms 
reproduce at a lower rate and are often less transmissible than their drug-susceptible counterparts 
[24]. However, the selective pressure applied by antibiotic treatment permits drug-resistant mutants 
to become the dominant strain in a patient infected with disease on first-line therapy and allows for 
further mutations with selection for fitness. Therefore, increasing drug-susceptible treatment rates 
may increase the likelihood of emergence of an even more prolific strain which also has drug 
resistance.  
 
In conclusion, this study has concentrated mainly on a two-strain coupled SIR epidemic model and 
performed a rigorous analytical analysis of the system properties and solutions, for understanding 
infectious diseases genetic variation and the rising threat of antibiotic resistance or inadequate 
treatment.  These results help inform the practice of drug treatment in the setting of drug resistance 
and emergent strains, such as is occurring in tuberculosis and other bacterial pathogens. Future 
studies could focus on specific pathogens (and their associated parameters) and whether treatment 
may lead to unintended threats to infection control such as increase in resistant strains.  
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